NVNO enVVeno Medical Corp
Nasdaq · SEC CIK 1661053 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $4,943 4 sales by 1 insiders
- Filings on record
- 56 since 2021-08-27, latest 2026-09-14 18:56
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Duhay Francis | Dir | — | $4,943 |
Transactions 26
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-14 18:56 | 2026-09-11 | NVNO | Duhay Francis | Dir | S - Sale | $11.21 | -11 | 2,351 | -0.5% | -$123.31 |
| T | 2026-06-12 16:05 | 2026-06-11 | NVNO | Duhay Francis | Dir | S - Sale | $10.30 | -140 | 2,362 | -6% | -$1,443 |
| 2026-03-13 | 2026-03-12 | NVNO | Duhay Francis | Dir | S - Sale | $11.52 | -140 | 2,502 | -5% | -$1,613 | |
| 2025-12-12 | 2025-12-11 | NVNO | Duhay Francis | Dir | S - Sale | $0.36 | -4,900 | 92.5K | -5% | -$1,764 | |
| 2025-09-17 | 2025-09-15 | NVNO | Duhay Francis | Dir | S - Sale | $0.83 | -4,900 | 97.4K | -5% | -$4,067 | |
| 2025-01-03 | 2024-12-31 | NVNO | Duhay Francis | Dir | P - Purchase | $3.07 | +81.4K | 102.3K | +389% | +$250.0K | |
| 2025-01-02 | 2024-12-31 | NVNO | Gray Robert | Dir | P - Purchase | $2.94 | +3,500 | 11.2K | +46% | +$10.3K | |
| 2024-12-26 | 2024-12-24 | NVNO | Shrivastava Sanjay | Dir | P - Purchase | $2.90 | +5,400 | 9,288 | +139% | +$15.7K | |
| 2024-12-23 | 2024-12-19 | NVNO | Jenusaitis Matthew | Dir | P - Purchase | $2.53 | +9,620 | 16.5K | +139% | +$24.3K | |
| 2024-12-19 | 2024-12-19 | NVNO | BERMAN ROBERT ANDREW | CEO, Dir | P - Purchase | $2.55 | +12.0K | 222.2K | +6% | +$30.6K | |
| D | 2024-03-15 | 2024-03-13 | NVNO | Alavi Hamed | CTO | S - Sale+OE | $6.22 | -8,334 | 0 | -100% | -$51.8K |
| D | 2024-03-15 | 2024-03-13 | NVNO | Alavi Hamed | CTO | M - OptEx | $3.59 | +8,334 | 8,334 | New | +$29.9K |
| D | 2022-09-16 | 2022-09-13 | NVNO | Jenusaitis Matthew | Dir | M - OptEx | — | +1,041 | 6,925 | +18% | — |
| D | 2022-09-16 | 2022-09-13 | NVNO | Gray Robert | Dir | M - OptEx | — | +1,041 | 7,655 | +16% | — |
| 2022-08-18 | 2022-08-16 | NVNO | Duhay Francis | Dir | P - Purchase | $6.14 | +7,751 | 20.9K | +59% | +$47.6K | |
| 2022-07-01 | 2022-06-30 | NVNO | Shrivastava Sanjay | Dir | P - Purchase | $3.85 | +1,000 | 3,888 | +35% | +$3,850 | |
| 2022-06-28 | 2022-06-27 | NVNO | BERMAN ROBERT ANDREW | CEO, Dir | P - Purchase | $3.80 | +2,500 | 210.2K | +1% | +$9,500 | |
| D | 2021-12-02 | 2021-11-30 | NVNO | Glickman Marc H. | SVP, Chief Medical Off | A - Grant | — | +100.0K | 101.6K | +6,250% | — |
| D | 2021-12-02 | 2021-11-30 | NVNO | Glynn Craig | CFO | A - Grant | — | +50.0K | 50.0K | New | — |
| D | 2021-12-02 | 2021-11-30 | NVNO | BERMAN ROBERT ANDREW | CEO, Dir | A - Grant | — | +200.0K | 207.7K | +2,585% | — |
| 2021-11-19 | 2021-11-19 | NVNO | BERMAN ROBERT ANDREW | CEO, Dir | P - Purchase | $7.43 | +2,000 | 7,736 | +35% | +$14.9K | |
| D | 2021-11-18 | 2021-11-16 | NVNO | Shrivastava Sanjay | Dir | M - OptEx | — | +388 | 2,888 | +16% | — |
| 2021-11-18 | 2021-11-16 | NVNO | BERMAN ROBERT ANDREW | CEO | P - Purchase | $7.87 | +2,000 | 5,736 | +54% | +$15.7K | |
| D | 2021-09-15 | 2021-09-13 | NVNO | Jenusaitis Matthew | Dir | M - OptEx | — | +1,042 | 5,884 | +22% | — |
| D | 2021-09-15 | 2021-09-13 | NVNO | Gray Robert | Dir | M - OptEx | — | +1,042 | 6,614 | +19% | — |
| 2021-08-27 | 2021-08-25 | NVNO | Jenusaitis Matthew | Dir | P - Purchase | $7.70 | +1,300 | 4,842 | +37% | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations